129 related articles for article (PubMed ID: 9611050)
1. Aztreonam plus piperacillin--empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy.
Fishman A; Chowers M; Altaras M; Beyth Y; Lang R
Eur J Gynaecol Oncol; 1998; 19(2):126-9. PubMed ID: 9611050
[TBL] [Abstract][Full Text] [Related]
2. Piperacillin plus aztreonam for treatment of neutropenic fever.
Takeuchi M; Tanizawa A; Mayumi M
Pediatr Int; 2003 Jun; 45(3):307-10. PubMed ID: 12828586
[TBL] [Abstract][Full Text] [Related]
3. [Aztreonam or gentamicin combined with piperacillin as empiric antibiotic therapy during neutropenia of patients with hematologic diseases].
Murase T
Kansenshogaku Zasshi; 1992 Feb; 66(2):121-6. PubMed ID: 1402071
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
[TBL] [Abstract][Full Text] [Related]
6. Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.
Kelsey SM; Shaw E; Newland AC
J Chemother; 1992 Apr; 4(2):107-13. PubMed ID: 1629747
[TBL] [Abstract][Full Text] [Related]
7. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
Gorschlüter M; Hahn C; Fixson A; Mey U; Ziske C; Molitor E; Horré R; Sauerbruch T; Marklein G; Schmidt-Wolf IG; Glasmacher A
Support Care Cancer; 2003 Jun; 11(6):362-70. PubMed ID: 12690546
[TBL] [Abstract][Full Text] [Related]
9. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Hess U; Böhme C; Rey K; Senn HJ
Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
[TBL] [Abstract][Full Text] [Related]
10. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin-tazobactam as empiric monotherapy in febrile neutropenic patients with haematological malignancies.
Hazel DL; Graham J; Dickinson JP; Newland AC; Kelsey SM
J Chemother; 1997 Aug; 9(4):267-72. PubMed ID: 9269607
[TBL] [Abstract][Full Text] [Related]
12. [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
Abs L; Kattan J; Culine S; Bekradda M; Farhat F; Droz JP
Bull Cancer; 1994 Oct; 81(10):871-6. PubMed ID: 7734770
[TBL] [Abstract][Full Text] [Related]
13. Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.
Kelsey SM; Weinhardt B; Collins PW; Newland AC
Eur J Clin Microbiol Infect Dis; 1992 Jun; 11(6):509-14. PubMed ID: 1388120
[TBL] [Abstract][Full Text] [Related]
14. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A
J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879
[TBL] [Abstract][Full Text] [Related]
15. Aztreonam therapy in children with febrile neutropenia: a randomized trial of aztreonam plus flucloxacillin versus piperacillin plus gentamicin.
Heney D; Lewis IJ; Ghoneim AT; Chisholm P; Bailey CC
J Antimicrob Chemother; 1991 Jul; 28(1):117-29. PubMed ID: 1769930
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients.
Chan CC; Oppenheim BA; Anderson H; Swindell R; Scarffe JH
Antimicrob Agents Chemother; 1989 Jan; 33(1):87-91. PubMed ID: 2653217
[TBL] [Abstract][Full Text] [Related]
17. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
[TBL] [Abstract][Full Text] [Related]
18. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
[TBL] [Abstract][Full Text] [Related]
19. Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
Cornely OA; Wicke T; Seifert H; Bethe U; Schwonzen M; Reichert D; Ullmann AJ; Karthaus M; Breuer K; Salzberger B; Diehl V; Fätkenheuer G
Int J Hematol; 2004 Jan; 79(1):74-8. PubMed ID: 14979482
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
Hirotsu T; Akatsuka J; Hoshi Y; Uchiyama H; Fujisawa K; Kobayashi N; Ishidoya N; Ohira M; Takayama J; Ishida Y
Jpn J Antibiot; 1990 Dec; 43(12):2069-77. PubMed ID: 2086821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
